145 related articles for article (PubMed ID: 38730506)
1. LncRNA NUTM2A-AS1 silencing inhibits glioma via miR-376a-3p/YAP1 axis.
Zeng Y; Yang Z; Yang Y; Wang P
Cell Div; 2024 May; 19(1):17. PubMed ID: 38730506
[TBL] [Abstract][Full Text] [Related]
2. Long Non-Coding RNA NUTM2A-AS1/miR-376a-3p/PRMT5 Axis Promotes Prostate Cancer Progression.
Han H; Li Z; Bi L; Zhang J
Arch Esp Urol; 2024 Mar; 77(2):173-182. PubMed ID: 38583010
[TBL] [Abstract][Full Text] [Related]
3. LncRNA NUTM2A-AS1 positively modulates TET1 and HIF-1A to enhance gastric cancer tumorigenesis and drug resistance by sponging miR-376a.
Wang J; Yu Z; Wang J; Shen Y; Qiu J; Zhuang Z
Cancer Med; 2020 Dec; 9(24):9499-9510. PubMed ID: 33089970
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of lncRNA NUTM2A-AS1 inhibits lung adenocarcinoma cell viability by regulating the miR-590-5p/METTL3 axis.
Wang J; Zha J; Wang X
Oncol Lett; 2021 Nov; 22(5):798. PubMed ID: 34630705
[TBL] [Abstract][Full Text] [Related]
5. LncRNA TTN-AS1 sponges miR-376a-3p to promote colorectal cancer progression via upregulating KLF15.
Wang Y; Jiang F; Xiong Y; Cheng X; Qiu Z; Song R
Life Sci; 2020 Mar; 244():116936. PubMed ID: 31610194
[TBL] [Abstract][Full Text] [Related]
6. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
7. H3K27ac-activated LncRNA NUTM2A-AS1 Facilitates the Progression of Colorectal Cancer Cells via MicroRNA-126-5p/FAM3C Axis.
Lin H; Hu S; Li Y; Li S; Teng D; Yang Y; Liu B; Du X
Curr Cancer Drug Targets; 2024 Feb; ():. PubMed ID: 38347779
[TBL] [Abstract][Full Text] [Related]
8. LncRNA ZEB1-AS1 Regulates Colorectal Cancer Cells by MiR-205/YAP1 Axis.
Jin Z; Chen B
Open Med (Wars); 2020; 15():175-184. PubMed ID: 32190742
[TBL] [Abstract][Full Text] [Related]
9. miR-376a inhibits glioma proliferation and angiogenesis by regulating YAP1/VEGF signalling via targeting of SIRT1.
Deng YW; Shu YG; Sun SL
Transl Oncol; 2022 Jan; 15(1):101270. PubMed ID: 34808462
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA GNAS-AS1 knockdown inhibits proliferation and epithelial-mesenchymal transition of lung adenocarcinoma cells via the microRNA-433-3p/Rab3A axis.
He J; Xi X; Cao P; Zhou J; Liu H; Li N
Open Med (Wars); 2023; 18(1):20230740. PubMed ID: 37465347
[TBL] [Abstract][Full Text] [Related]
11. LncRNA DCST1-AS1 regulated cell proliferation, migration, invasion and apoptosis in gastric cancer by targeting miR-605-3p.
Su YZ; Cui MF; Du J; Song B
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1158-1167. PubMed ID: 32096164
[TBL] [Abstract][Full Text] [Related]
12. LncRNA PSMB8-AS1 increases glioma malignancy via the miR-382-3p/BCAT1 axis.
Liu H; Zhang J; Li J; Cao X; Yu K; Xia X; Li Z; Wang F
Transl Oncol; 2024 Jan; 39():101806. PubMed ID: 38235619
[TBL] [Abstract][Full Text] [Related]
13. LncRNA NUTM2A-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway.
Long J; Liu L; Yang X; Zhou X; Lu X; Qin L
Hum Cell; 2023 Jan; 36(1):312-328. PubMed ID: 36242728
[TBL] [Abstract][Full Text] [Related]
14. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
Li GH; Yu JH; Yang B; Gong FC; Zhang KW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
[TBL] [Abstract][Full Text] [Related]
15. LncRNA
Li Z; Li M; Xia P; Wang L; Lu Z
Cancer Manag Res; 2021; 13():9037-9048. PubMed ID: 34916848
[TBL] [Abstract][Full Text] [Related]
16. NUTM2A-AS1 silencing alleviates LPS-induced apoptosis and inflammation in dental pulp cells through targeting let-7c-5p/HMGB1 axis.
Wang X; Sun H; Hu Z; Mei P; Wu Y; Zhu M
Int Immunopharmacol; 2021 Jul; 96():107497. PubMed ID: 33831808
[TBL] [Abstract][Full Text] [Related]
17. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MSC-AS1, as an oncogene in melanoma, promotes the proliferation and glutaminolysis by regulating the miR-330-3p/ YAP1 axis.
Tian T; Luo B; Shen G; Ji G
Anticancer Drugs; 2022 Nov; 33(10):1012-1023. PubMed ID: 36206100
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA LINC00488 facilitates thyroid cancer cell progression through miR-376a-3p/PON2.
Xie F; Li L; Luo Y; Chen R; Mei J
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33600548
[TBL] [Abstract][Full Text] [Related]
20. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer.
Sun J; Min H; Yu L; Yu G; Shi Y; Sun J
Anticancer Drugs; 2021 Jan; 32(1):11-21. PubMed ID: 33290312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
